Juan José Gorgojo Martínez

Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus

Juan José Gorgojo Martínez, Pedro Mezquita‐Raya, Juana Carretero‐Gómez et al. · Journal of Clinical Medicine · 2022 · 242 citations · Full text

Obesity, Translational Medicine, Gastrointestinal Peptide Hormone +14

Effectiveness and tolerability of orlistat and liraglutide in patients with obesity in a real‐world setting: The XENSOR Study

Juan José Gorgojo Martínez, Belen Basagoiti‐Carreño, Alberto Sanz‐Velasco et al. · International Journal of Clinical Practice · 2019 · 79 citations

Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery

Juan José Gorgojo Martínez, Gara Feo-Ortega, Clara Serrano‐Moreno · Surgery for Obesity and Related Diseases · 2016 · 57 citations

Obesity, Metabolic Syndrome, Bariatric Surgery +10

Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance

Akshay Jain, Amar Ali, Juan José Gorgojo Martínez et al. · International Journal of Clinical Practice · 2020 · 39 citations · Full text

Real-world effectiveness and safety of dapagliflozin therapy added to a GLP1 receptor agonist in patients with type 2 diabetes

Juan José Gorgojo Martínez, Clara Serrano‐Moreno, Alberto Sanz‐Velasco et al. · Nutrition Metabolism and Cardiovascular Diseases · 2016 · 28 citations

Metabolic Syndrome, Diabetes Management, Medicine +7